{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:59:43Z","timestamp":1766415583807,"version":"3.48.0"},"reference-count":54,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1080\/14712598.2025.2597847","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:40:26Z","timestamp":1765543226000},"page":"1223-1232","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Bispecific antibody combination regimens for B-cell non-Hodgkin\u2019s lymphomas"],"prefix":"10.1080","volume":"25","author":[{"given":"Khushali","family":"Jhaveri","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Saha","sequence":"additional","affiliation":[{"name":"University of Alabama","place":["Birmingham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Miguel","family":"Juarez-Salcedo","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Princesa","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-6238","authenticated-orcid":false,"given":"Julio C.","family":"Chavez","sequence":"additional","affiliation":[{"name":"Mayo Clinic","place":["Jacksonville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01622-0"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285343"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000025"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00166-2"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00335-7"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02410-8"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198714"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194333"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7020"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025454"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01364-2"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00921-6"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2239"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02470"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00889-8"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03175"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02329"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200190"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016845"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7015"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01774-4"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022154"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02726-5"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194581"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70110_LBA3"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_50"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3163_135"},{"issue":"16","key":"e_1_3_4_41_1","first-page":"7014","article-title":"Epcoritamab with rituximab + lenalidomide (R2) in previously untreated (1L) follicular lymphoma and epcoritamab maintenance in FL: results from EPCORE NHL-2 arms 6 & 7","volume":"42","author":"Leslie LA","year":"2024","unstructured":"Leslie LA, Falchi L, Vermaat JSP, et al. Epcoritamab with rituximab + lenalidomide (R2) in previously untreated (1L) follicular lymphoma and epcoritamab maintenance in FL: results from EPCORE NHL-2 arms 6 & 7. J Clin Oncol. 2024;42(16 Suppl):7014.","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199301"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967800.55471.36"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198452"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)02258-X"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7032"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029117"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100096"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19455"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022348"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025355"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)02300-6"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198023"},{"key":"e_1_3_4_54_1","volume-title":"Durable efficacy with fixed-duration epcoritamab + polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) for 1L diffuse large B-cell lymphoma (EPCORE NHL-5)","author":"Kerr D","year":"2025","unstructured":"Kerr D, Lavie D, Abraham A, et al. Durable efficacy with fixed-duration epcoritamab + polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) for 1L diffuse large B-cell lymphoma (EPCORE NHL-5). EHA Library; 2025."},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70094_280"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_74"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2025.2597847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:50:39Z","timestamp":1766415039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2025.2597847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,2]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["10.1080\/14712598.2025.2597847"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2025.2597847","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"type":"print","value":"1471-2598"},{"type":"electronic","value":"1744-7682"}],"subject":[],"published":{"date-parts":[[2025,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}